Cleared Traditional

K230100 - SCIZER (SC1-M410) (FDA 510(k) Clearance)

Nov 2023
Decision
294d
Days
Class 2
Risk

K230100 is an FDA 510(k) clearance for the SCIZER (SC1-M410). This device is classified as a Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (Class II - Special Controls, product code OHV).

Submitted by Classys, Inc. (Seoul, KR). The FDA issued a Cleared decision on November 3, 2023, 294 days after receiving the submission on January 13, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4590. A Device Using Focused Ultrasound To Produce Localized, Mechanical Motion Within Tissues And Cells For The Purpose Of Producing Either Localized Heating For Tissue Coagulation Or For Mechanical Cellular Membrane Disruption Intended For Non-invasive Aesthetic Use..

Submission Details

510(k) Number K230100 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 2023
Decision Date November 03, 2023
Days to Decision 294 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OHV - Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4590
Definition A Device Using Focused Ultrasound To Produce Localized, Mechanical Motion Within Tissues And Cells For The Purpose Of Producing Either Localized Heating For Tissue Coagulation Or For Mechanical Cellular Membrane Disruption Intended For Non-invasive Aesthetic Use.